Navigation Links
Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
Date:10/31/2011

BLUE BELL, Pa., Oct. 31, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon® vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 Promising Therapeutic Vaccines (see VGX-3100 – Cervical cancer). Inovio is currently enrolling patients with CIN 2/3 or CIN 3 cervical dysplasias in its Phase II clinical study being conducted in multiple centers around the US and sites in Canada, Korea, South Africa and Australia.

The article noted: "Fierce Vaccines spotlights 10 therapeutic vaccines now being tested in humans and generating buzz. Those for cancer get the most attention, in part because their anticipated gentleness stands in such stark contrast to the known toxicities of conventional chemotherapies….

"[Inovio's] VGX-3100 is a therapeutic DNA vaccine candidate, now in Phase II testing for the treatment of cervical dysplasia and cancer caused by human papillomavirus (HPV) types 16 and 18. These sexually transmitted strains are thought to cause up to 70% of cervical cancer cases. Inovio is conducting Phase II clinical trials of related vaccine candidates based on DNA associated with leukemia and hepatitis C virus, and Phase I studies for influenza and HIV. The company's vaccine candidates are similar to gene therapy, in that they are designed to insert into patients' cells a piece of DNA coding for an antigenic protein related to a particular disease. In theory, if enough DNA can get into cells even temporarily, those cells will prod
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Dans ... santé, le ferroviaire ou encore l,énergie, les ... progressivement accès à leurs données. Ces données ... installés au cœur des voitures, trains, avions, ... de milliards le nombre de machines connectées ...
(Date:9/23/2014)... , Sept. 23, 2014  Decision Resources ... reimbursement (P&R) decision criteria and payer requirements ... insights into each country, allow pharma to ... markets.  Global market access is extremely complex, ... access requirements and challenges—and a vast variety ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
Breaking Medicine Technology:Altran transforme le big data du monde industriel en nouveau business 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4
... , WASHINGTON, Jan. 11 ... Baseball star Aaron Boone is featured in January on , Sharing ... that tells the compelling and inspirational stories of real patients. , Sharing ... is sponsored by the Pharmaceutical Research and Manufacturers of America ...
... , , SAN JOSE, Calif., Jan. ... and control solutions for life sciences process applications, announced ... TruFluor sensors for dissolved oxygen or pH and process ... family is optimized for accuracy, lifetime, and ease of ...
Cached Medicine Technology:Major League Baseball Star Aaron Boone on 'Sharing Miracles' 2Major League Baseball Star Aaron Boone on 'Sharing Miracles' 3Single-Use Sensor Product Family Enters High Volume Production 2
(Date:9/23/2014)... Dennis Thompson HealthDay Reporter ... Coupled with worldwide marches demanding action on climate change, ... weather patterns in the United States may soon exacerbate ... and other heat-related illnesses are expected to increase as ... author Dr. Jonathan Patz, director of the Global Health ...
(Date:9/23/2014)... at Cincinnati Children,s Hospital Medical Center have published ... (EG). The study, published in The Journal ... EG is a systemic disorder that has high ... tract, involves a series of allergy-associated-immune mechanisms and ... distinct from that of a related disorder, eosinophilic ...
(Date:9/23/2014)... a potential source of student diversity for medical ... however, there are significant challenges to enhancing the ... medical schools. The authors recommend that medical school ... be more inclusive of community college students. , ... Francisco and San Jose City College found that, ...
(Date:9/23/2014)... shows that adolescents who suffer from sleep disturbance or ... academically compared to those who enjoy a good night,s ... journal Sleep Medicine . , In a new ... and 19 from Uppsala County, researchers from Uppsala University ... sleep duration (less than 7 hours per day) increased ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 If ... ongoing dialysis, dressing for the treatment may be a ... a type of garment that is designed to improve ... patients to receive dialysis without having to remove, tear ... while insuring privacy and preserving their dignity. At the ...
Breaking Medicine News(10 mins):Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3Health News:Advancing the understanding of an understudied food allergy disorder 2Health News:Advancing the understanding of an understudied food allergy disorder 3Health News:Medical students who attended community college likelier to serve poor communities 2Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2
... a quarter million deaths in the United States annually, ... as prescribed . A Mayo Clinic research team has ... medications. The tool is clearly effective and preferred by ... in the May 28 issue of the Archives of ...
... increase levels of high-density lipoprotein, or 'good,' ... issue of Archives of Internal Medicine. ... is an independent risk factor for cardiovascular disease, ... background information in the article. There is strong ...
... better predict the likelihood of full or partial recovery ... according to a study published in the June issue ... that the possibility and extent of neurological recovery after ... by rigorous assessment of MR images," said co-author Michael ...
... Asia - including India's - met European Union members in ... crises. ,The two-day Asia-Europe Meeting (ASEM) of 43 ... seeking deep cuts in world carbon-dioxide emissions and Asian governments ... held every two years. India, Pakistan and Mongolia are attending ...
... multidetector computed tomography (MDCT) can aid forensics teams in ... study published in the June issue of Radiology . ... demonstrating airway froth and sediment that are indicative of ... be used either to facilitate or reduce the need ...
... genes may actually contribute to learning the supposed "tonal languages", ... of Edinburgh University, UK, have exposed the first obvious connection ... in tonal languages can fundamentally alter the meaning of words, ... are so tough to learn for speakers of non-tonal languages ...
Cached Medicine News:Health News:Simple Tool Developed for Diabetics to Improve Compliance With Medications 2Health News:Simple Tool Developed for Diabetics to Improve Compliance With Medications 3Health News:Regular Exercise may Slightly Increase HDL Levels 2Health News:Recovery from Spinal Cord Injury can Be Predicted Using MRI 2Health News:EU Pushes Asian Nations on Climate Change Goals 2Health News:Death Due to Drowning can Be Identified With the Aid of 'Virtual Autopsy' 2Health News:Genes may Have a Role in Learning "tonal Languages" 2
... manufactures slides that are compatible with multichannel ... the number of pipetting steps required to ... on the slides. Ask Immuno Concepts for ... slides. These slide formats are noted with ...
... ANA uses a patented HEp-2 cell line ... the sensitivity to SS-A/Ro autoantibodies, without affecting ... studies have been published worldwide on the ... to SS-A/Ro autoantibodies when used in place ...
... and ENA assays can be used ... antinuclear antibodies, which are associated with ... Systemic lupus erythematosus (Lupus), Sjgren's syndrome, ... sclerosis, scleroderma, polymyositis, dermatomyositis, and Raynaud's ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
Medicine Products: